NYXH (NYXH) Stock Price & Analysis
NYXH (NYXH) fell 3.60% to USD 1.34 as of June 10, 2026 at 07:07 UTC, according to Nexqual real-time market data.
NYXH last closed at USD 1.39; the session ranged USD 1.28–1.49 on volume of 970,477 shares. Market capitalization is $133.90M, with a 52-week range of USD 1.28–8.59 (NGM). Source: Nexqual, June 10, 2026 at 07:07 UTC.
Key Statistics (as of June 10, 2026 at 07:07 UTC)
| Price | USD 1.34 |
|---|---|
| Change | ▼ 3.60% (down) |
| Previous Close | USD 1.39 |
| Open | USD 1.42 |
| Day Range | USD 1.28 – 1.49 |
| 52-Week Range | USD 1.28 – 8.59 |
| Volume | 970,477 shares |
| Market Cap | $133.90M |
| Exchange | NGM |
Technical Analysis (NYXH)
Nexqual's technical model rates NYXH "SELL" based on 3 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 07:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 18.02 (oversold) |
| vs SMA50 | Below (USD 2.98) |
| MACD | -0.26 (negative) |
Analyst Ratings (NYXH)
Wall Street analysts rate NYXH "Buy" based on 4 analysts, with a mean price target of USD 8.91 (range USD 4.93–12.83), per Nexqual as of June 10, 2026 at 07:07 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 8.91 |
| High Target | USD 12.83 |
| Low Target | USD 4.93 |
| Buy / Hold / Sell | 3 / 2 / 0 |
Earnings (NYXH)
| Next Earnings Date | 2026-08-05 |
|---|---|
| EPS Estimate | USD -0.44 |
| Revenue Estimate | $7.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.59 vs est -0.55 ▼ miss |
| 2025-09-30 | USD -0.63 vs est -0.56 ▼ miss |
| 2025-06-30 | USD -0.55 vs est -0.57 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:07 UTC.
Financials & Fundamentals (NYXH)
| Total Revenue | $15.33M |
|---|---|
| Revenue Growth (YoY) | +498.90% |
| Gross Margin | +60.71% |
| Operating Margin | -321.72% |
| Profit Margin | +0.00% |
| ROE | -129.97% |
| Debt / Equity | 100.58 |
| Current Ratio | 0.99 |
| Total Cash | $25.93M |
| Total Debt | $36.08M |
| Free Cash Flow | $-45.77M |
Source: Nexqual, June 10, 2026 at 07:07 UTC.
Financial Health Score (NYXH)
Nexqual rates NYXH's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:07 UTC.
| Growth | Strong — Revenue +122% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Weak — $26M cash vs $36M debt |
| Cash Flow | Weak — FCF negative: -$46M, burning cash |
| Efficiency | Critical — ROE -130%, ROA -44.6% |
Ownership (NYXH)
| Insider Ownership | +16.18% |
|---|---|
| Institutional Ownership | +9.52% |
| Shares Outstanding | 99.93M |
| Float | 24.49M |
| Short % of Float | +1.30% |
Source: Nexqual, June 10, 2026 at 07:07 UTC.
Leadership (NYXH)
NYXH is led by Olivier Taelman (age 53), CEO & Executive Director, per Nexqual as of June 10, 2026 at 07:07 UTC.
| CEO & Executive Director | Olivier Taelman (age 53) |
|---|---|
| Co-Founder & Chairman | Robert Taub (age 78) |
| Chief Financial Officer | John Landry (age 52) |
| President of International | Loic Moreau (age 45) |
Major Backers & Investors (NYXH)
Notable institutional backers of NYXH include Vestal Point Capital, LP, BNP Paribas Asset Management Holding S.A., Andera Partners, according to Nexqual as of June 10, 2026 at 07:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Vestal Point Capital, LP | 1.94% |
| BNP Paribas Asset Management Holding S.A. | 1.69% |
| Andera Partners | 1.17% |
| Heights Capital Management, Inc | 0.69% |
| Rossmore Private Capital | 0.3% |
| IFP Advisors, Inc | 0.2% |
| Sio Capital Management, LLC | 0.11% |
| Ikarian Capital, LLC | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 2.21% |
Source: Nexqual, June 10, 2026 at 07:07 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NPCE | Neuropace, Inc. | USD 15.96 | ▲ 1.4% |
| CVRX | CVRx, Inc. | USD 5.2 | ▼ 3.35% |
| MOLN | Molecular Partners AG | USD 3.88 | ▼ 5.37% |
| SGHT | Sight Sciences, Inc. | USD 4.85 | ▲ 8.99% |
| SERA | Sera Prognostics, Inc. | USD 2.13 | ▼ 6.99% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:07 UTC. This page is informational and not investment advice.